1. Home
  2. SLS vs TOYO Comparison

SLS vs TOYO Comparison

Compare SLS & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • TOYO
  • Stock Information
  • Founded
  • SLS 2012
  • TOYO 2022
  • Country
  • SLS United States
  • TOYO Japan
  • Employees
  • SLS N/A
  • TOYO N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • TOYO
  • Sector
  • SLS Health Care
  • TOYO
  • Exchange
  • SLS Nasdaq
  • TOYO NYSE
  • Market Cap
  • SLS 169.6M
  • TOYO 153.8M
  • IPO Year
  • SLS N/A
  • TOYO N/A
  • Fundamental
  • Price
  • SLS $1.54
  • TOYO $3.73
  • Analyst Decision
  • SLS
  • TOYO
  • Analyst Count
  • SLS 0
  • TOYO 0
  • Target Price
  • SLS N/A
  • TOYO N/A
  • AVG Volume (30 Days)
  • SLS 2.6M
  • TOYO 17.9K
  • Earning Date
  • SLS 08-12-2025
  • TOYO 05-15-2025
  • Dividend Yield
  • SLS N/A
  • TOYO N/A
  • EPS Growth
  • SLS N/A
  • TOYO 350.49
  • EPS
  • SLS N/A
  • TOYO 1.09
  • Revenue
  • SLS N/A
  • TOYO $176,957,128.00
  • Revenue This Year
  • SLS N/A
  • TOYO N/A
  • Revenue Next Year
  • SLS N/A
  • TOYO N/A
  • P/E Ratio
  • SLS N/A
  • TOYO $3.43
  • Revenue Growth
  • SLS N/A
  • TOYO 183.69
  • 52 Week Low
  • SLS $0.77
  • TOYO $1.36
  • 52 Week High
  • SLS $2.12
  • TOYO $8.34
  • Technical
  • Relative Strength Index (RSI)
  • SLS 45.96
  • TOYO N/A
  • Support Level
  • SLS $1.47
  • TOYO N/A
  • Resistance Level
  • SLS $1.73
  • TOYO N/A
  • Average True Range (ATR)
  • SLS 0.11
  • TOYO 0.00
  • MACD
  • SLS -0.02
  • TOYO 0.00
  • Stochastic Oscillator
  • SLS 19.44
  • TOYO 0.00

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About TOYO TOYO CO LTD

Toyo Co Ltd along with its subsidiaries, is engaged in research and development, production, and sales of solar cells. Geographically, the company generates revenue from Asia and the USA, out of which the majority of revenue is generated from Asia.

Share on Social Networks: